Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.

B Charbonnel

Journal: International journal of clinical practice. Supplement 2007

PMID: 17594387

View on PubMed

Abstract

Address: Clinique d'endocrinologie, Maladies metaboliques et nutrition, Nantes Cedex, France. [email protected]

DOI: 10.1111/j.1742-1241.2007.01394.x

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetestype2.html

MeSH Terms: Diabetes Mellitus, Type 2, Drug Therapy, Combination, Humans, Hypoglycemic Agents, Sulfonylurea Compounds, Thiazolidinediones

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.